Related Experiment Video

Updated: Oct 15, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin

M Kullin1, Z Li, J B Hansen

  • 1Department of Medical Sciences, Uppsala University, Sweden.

Diabetes
|July 26, 2000
PubMed

Insights

K(ATP) channel openers, diazoxide and NNC 55-0118, protected pancreatic beta-cells from streptozotocin-induced damage. NNC 55-0118 demonstrated superior protective effects, preserving cell morphology and function.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Streptozotocin (STZ) induces experimental beta-cell damage, mimicking aspects of Type 1 diabetes.
  • K(ATP) channels play a crucial role in beta-cell function and survival.

Purpose of the Study:

  • To investigate the protective effects of K(ATP) channel openers, diazoxide and NNC 55-0118, against STZ-induced beta-cell damage.
  • To elucidate the potential therapeutic applications of these compounds in conditions involving beta-cell injury.

Main Methods:

  • Rat pancreatic islets were exposed to STZ alone or in combination with varying concentrations of diazoxide or NNC 55-0118.
  • Cellular morphology, glucose oxidation, insulin content, and insulin secretion were assessed after 24 hours of culture.
  • NAD levels were measured to explore potential mechanisms of action.

Main Results:

  • STZ exposure caused significant beta-cell damage, including impaired morphology, reduced glucose oxidation, and diminished insulin secretion.
  • Co-administration of diazoxide and NNC 55-0118 dose-dependently protected beta-cells from STZ-induced damage.
  • NNC 55-0118 exhibited a more potent protective effect than diazoxide, fully counteracting STZ-induced impairments.
  • NNC 55-0118 did not prevent STZ-induced NAD depletion, suggesting its protective mechanism is independent of poly(ADP-ribose) polymerase inhibition.

Conclusions:

  • K(ATP) channel openers, particularly NNC 55-0118, offer significant protection against STZ-induced beta-cell toxicity.
  • These findings suggest a potential therapeutic strategy for protecting insulin-producing cells in inflammatory conditions like insulitis.

More Related Videos

Pancreatic Islet Isolation and Purification from Lewis Rats Using Enzymatic Digestion and Density-Gradient Separation07:44

Pancreatic Islet Isolation and Purification from Lewis Rats Using Enzymatic Digestion and Density-Gradient Separation

Published on: April 3, 2026

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...